Actively Recruiting
Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)
Led by Sanofi Pasteur, a Sanofi Company · Updated on 2025-12-01
50
Participants Needed
1
Research Sites
375 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary Objective: To assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women vaccinated with MenQuadfi® during pregnancy or in the 30 days preceding their Last Menstrual Period (LMP).
CONDITIONS
Official Title
Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women and their offspring residing in the US or its territories
- Exposure to MenQuadfi4 vaccine during pregnancy or within 30 days before last menstrual period
- Sufficient evidence confirming vaccination timing during pregnancy or within 30 days before last menstrual period
- Vaccine name provided or identified as a meningococcal vaccine from an unknown manufacturer
- Exposure reported to the pregnancy registry
You will not qualify if you...
- Reports from clinical trials are excluded; only post-marketing spontaneous case reports are included
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pennsylvania Locations
Swiftwater, Pennsylvania, United States, 18370-0187
Actively Recruiting
Research Team
T
Trial Transparency email recommended (Toll free number for US & Canada)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here